Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Astellas Pharma Inc    4503   JP3942400007

SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets
Latest news on ASTELLAS PHARMA INC
08/10 ASTELLAS PHARMA : Studies from Astellas Pharma in the Area of Diabetes Described..
08/03 ASTELLAS PHARMA : Recent Findings in Information and Data Management Described b..
08/01 ASTELLAS PHARMA : LTL Pharma Succeeds Marketing Approval for "Nivadil® Tablets",..
08/01 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares (pdf 329KB)
07/28 ASTELLAS PHARMA : Announces Acquisition of Own Shares (pdf 310KB)
07/28 ASTELLAS PHARMA : Reports First Quarter FY2017 Financial Results (pdf 434KB)
07/28 ASTELLAS PHARMA : Reports First Quarter FY2017 Financial Results
07/27 NEW TYPE 2 DIABETES STUDY FINDINGS R : ...
07/21 ASTELLAS PHARMA : U.S. FDA Grants Orphan-Drug Designation to Astellas for Develo..
07/13 ASTELLAS PHARMA : Supports the Northern Kyushu Heavy Rain Relief Efforts
07/12 ASTELLAS PHARMA : Presentation material for Press Conference on July 11th (1.76 ..
07/07 ASTELLAS PHARMA : Maruho Succeeds Marketing Approval for Anti-Atopic Dermatitis ..
07/06 ASTELLAS PHARMA : Submits Supplemental New Drug Application for Mirabegron for U..
07/05 ASTELLAS PHARMA : Named to FTSE4Good Sustainability Index for the Sixth Consecut..
06/30 Global Pertussis Vaccine Market 2017 - Sanofi Pasteur, Astellas Pharma, Life ..
06/24 ASTELLAS UK : Suspension from Membership of the ABPI to be Extended for 12 Month..
06/23 ASTELLAS PHARMA : president wants people to focus on lives saved by pharmaceutic..
06/22 ASTELLAS PHARMA : Drug company president wants people to focus on lives saved by..
06/21 ASTELLAS PHARMA : The Astellas Oncology C3 Prize Competition Returns for a Secon..
06/15 ASTELLAS PHARMA : and Pfizer Announce Amendment to Clinical Research Protocol fo..
06/15 ASTELLAS PHARMA : White & Case Advises Ogeda Shareholders on Sale to Astellas Ph..
06/10 PFIZER : Astellas, Pfizer Announce Amendment to Clinical Research Protocol for P..
06/09 ASTELLAS PHARMA : Researchers Submit Patent Application, "Treatment Regimen Tiac..
06/09 ASTELLAS PHARMA : Patent Application Titled "Pharmaceutical Composition for Oral..
06/09 ASTELLAS PHARMA : New Data from Astellas Pharma Illuminate Findings in Type 2 Di..
06/09 ASTELLAS PHARMA : and Pfizer Announce Amendment to Clinical Research Protocol fo..
06/08 ASTELLAS PHARMA : Announces Record Number of Abstracts Highlighting Breadth and ..
06/05 ASTELLAS PHARMA : Kyoto University and Astellas Inaugurate "Alliance Station" wi..
06/01 ASTELLAS PHARMA : Data on Proinsulin Detailed by Researchers at Astellas Pharma ..
06/01 ASTELLAS PHARMA : Announces Commitments to GHIT Fund Replenishment
05/25 ASTELLAS PHARMA : Announces Record Number of Abstracts Highlighting Breadth and ..
05/19 ASTELLAS PHARMA : MSD submits application for approval of type-2 diabetes drug c..
05/18 ASTELLAS PHARMA : Data on Pain Reported by Researchers at Astellas Pharma (Effec..
05/18 ASTELLAS PHARMA : Announces Decision to Discontinue ASP8273 Treatment and Close ..
05/18 NANOSTRING TECHNOLOGIES, INC. (NASDA : NSTG) Files An 8-K Other Events
05/15 ASTELLAS PHARMA : Announces Continuation of Performance-linked Stock Compensatio..
05/12 ASTELLAS PHARMA : Announces Decision to Discontinue ASP8273 Treatment and Close ..
05/11 ASTELLAS PHARMA : The Institute of Medical Science, the University of Tokyo, and..
05/01 TRANSFER OF 16 LONG-LISTED PRODUCTS : Closing of Asset Purchase Agreement
04/28 TRANSFER OF 16 LONG-LISTED PRODUCTS : Closing of Asset Purchase Agreement
04/27 ASTELLAS PHARMA : Researchers from Astellas Pharma Report New Studies and Findin..
04/27 ASTELLAS PHARMA : Researchers at Astellas Pharma Global Development Inc. Have Re..
04/27 ASTELLAS PHARMA : Researchers from Astellas Pharma Describe Findings in Pharmace..
04/27 ASTELLAS PHARMA : - Changes of Representative Directors and Directors
04/27 ASTELLAS PHARMA : Announces Cancellation of Treasury Shares (pdf 266KB)
04/27 ASTELLAS PHARMA : Announces Cancellation of Treasury Shares
04/27 ASTELLAS PHARMA : Changes of Representative Directors and Directors (pdf 294KB)
04/27 ASTELLAS PHARMA : Reports Full Year FY2016 Financial Results (462 KB)
04/27 ASTELLAS PHARMA : Reports Full Year FY2016 Financial Results
04/20 ASTELLAS PHARMA : Recent Findings from Astellas Pharma Has Provided New Informat..
04/13 ASTELLAS PHARMA : to Acquire Ogeda SA
04/13 ASTELLAS PHARMA : Findings from Astellas Pharma Provides New Data about Pain (Th..
04/06 ASTELLAS PHARMA : Reports from Astellas Pharma Provide New Insights into Urothel..
04/06 ASTELLAS PHARMA : New Amino Acids Data Have Been Reported by Researchers at Aste..
04/06 ASTELLAS PHARMA : Reports Outline Rheumatoid Arthritis Study Findings from Astel..
04/03 ASTELLAS PHARMA : to acquire Belgian drug company in deal valued at as much as $..
04/03 ASTELLAS PHARMA : to acquire Belgium firm for up to 800 mil. euros
04/03 ASTELLAS PHARMA : To Buy Ogeda
04/03 ASTELLAS PHARMA : to Acquire Ogeda SA (pdf 306KB)
03/29 ASTELLAS PHARMA : Transfer of 16 Long-Listed Products in Japan
03/29 ASTELLAS PHARMA INC : ex-dividend day for final dividend
03/23 NEW CHROMATOGRAPHY STUDY FINDINGS HA : A Pitfall Associated...
03/23 ASTELLAS PHARMA : Findings from Astellas Pharma Provide New Insights into Urothe..
03/23 ASTELLAS PHARMA : Announces Status of Acquisition of Own Shares
03/23 CYTOKINETICS : Announces Preclinical Data for CK-2127107 Presented at MDA Scient..
03/23 ASTELLAS PHARMA : Notice of Completion of Acquisition of Own Shares (pdf 189KB)
03/22 ASTELLAS PHARMA : Launch of LINZESS® Tablets 0.25mg in Japan
03/16 ASTELLAS PHARMA : Researchers from Astellas Pharma Discuss Findings in Liver Can..
03/13 ASTELLAS PHARMA : Work begins on new pneumococcus vaccine
03/09 ASTELLAS PHARMA : Study Findings on Anemia Are Outlined in Reports from Astellas..
02/28 ASTELLAS PHARMA : and Affinivax Announce Worldwide Partnership for MAPS Vaccine ..
02/27 LUPIN : subsidiary Kyowa gets right to distribute quetiapine fumarate tablets in..
02/27 ASTELLAS PHARMA : Kyowa and Astellas enter into an Agreement for Exclusive Distr..
02/24 ASTELLAS PHARMA : Study Results from Astellas Pharma, Inc. Provide New Insights ..
02/23 ASTELLAS PHARMA : Joint Storage and Transportation of Pharmaceuticals in Hokkaid..
1  2  3  4  5  6  7Next
Financials ( JPY)
Sales 2018 1 291 938 M
EBIT 2018 260 000 M
Net income 2018 192 997 M
Finance 2018 395 258 M
Yield 2018 2,61%
P/E ratio 2018 14,86
P/E ratio 2019 14,42
EV / Sales 2018 1,91x
EV / Sales 2019 1,85x
Capitalization 2 857 045 M
Chart ASTELLAS PHARMA INC
Duration : Period :
Astellas Pharma Inc Technical Analysis Chart | 4503 | JP3942400007 | 4-Traders
Technical analysis trends ASTELLAS PHARMA INC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 1 505  JPY
Spread / Average Target 9,0%
EPS Revisions
Managers
NameTitle
Yoshihiko Hatanaka President, CEO & Representative Director
Yasumasa Masuda Chief Financial Officer
Mitsunori Matsuda Senior Executive Officer & President-Technology
Yoshiro Miyokawa Representative Director & Executive Vice President
Hironobu Yasuda Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
ASTELLAS PHARMA INC-15.07%26 156
JOHNSON & JOHNSON15.12%355 979
NOVARTIS8.84%216 915
ROCHE HOLDING LTD.4.99%216 699
PFIZER0.59%194 554
MERCK AND COMPANY4.45%167 705